Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil

Abstract

Objective: To evaluate the association between adherence to treatment and mortality among Chronic Obstructive Pulmonary Disease (COPD) patients treated in the Brazilian public health system. Methods: This is cohort study of moderate-to-severe COPD patients monitored in a public pharmaceutical care-based Disease Management Program (DMP). All subjects who died one year after the beginning of the cohort were age-matched with those who remained alive at the end of the cohort period. Treatment adherence was measured through pharmacy records. Patients who received at least 90% of the prescribed doses were considered adherent to treatment. Results: Of the 333 patients (52.8% age = 65 years, 67.9% male), 67.3% were adherent to treatment (adherence rate, 87.2%). Mortality was associated with lack of adherence (p = 0.04), presence of symptoms (mMRC = 2) and COPD treatment use. The death was associated with non-adherence, presence of symptoms and previous hospitalization. After adjustment, non-adherent patients to treatment were almost twice times likely to die compared to those adherents (Hazard Ratio (HR) 1.86; CI 1.16-2.98, p = 0.01). Conclusion: Non-adherence to treatment was associated with higher mortality among moderate-to-severe COPD patients treated in the Brazilian public health system. Strategies to monitor and optimize adherence should be strengthened to reduce COPD-related mortality.

Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer

“…Latest research by the Turkish Pharmacists Association shows that community pharmacists trained in pharmacy services, asthma, COPD, diabetes and hypertension can improve the health status of patients through the provision of pharmaceutical care,44 which provides direction for continuing education of pharmacists. Other studies have found that patients with moderate to severe COPD who do not adhere to treatment have a higher mortality rate, pointing out that such patients should strengthen monitoring and optimise drug treatment adherence strategies 45. In summary, community pharmacist-led intervention is effective in improving medication compliance and clinical efficacy in patients with hypertension, asthma and COPD 34…”

Implementation of a pharmacist‐driven chronic obstructive pulmonary disease transitions of care service at a large academic medical center

“…Non-adherence to inhalers and other COPD treatments has been associated with increased risk of exacerbations, worsening COPDrelated symptoms, higher healthcare utilization, increased costs, decreased quality of life and higher rates of mortality. [25][26][27][28][29] In our study, medication adherence was assessed in all 30 patients by asking a standardized question: "In the past 7 days prior to admission how many times did you forget to take your medications as prescribed? "…”

Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A retrospective cohort study

“…From these results, transdermal tulobuterol for stable COPD in stroke patients may have no short-term benefit, even among those with severe neurologic dysfunction, compared with no treatment. Additionally, since interruption of inhaler treatment was previously associated with worse COPD outcomes, [10,11] efforts should be first made to continue effective treatment with inhalers, even if transdermal tulobuterol is available. This involves assessing the patient inhaler techniques, selecting appropriate devices based on the patient ability, [20] and support from caregivers.…”

“…Such non-adherence to the proper treatment for COPD increases the frequency of acute exacerbations [10] and mortality. [11] Additionally, discontinuing COPD treatment may worsen outcomes in patients with COPD who develop acute stroke.…”